2023
Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy
Hertz D, Tofthagen C, Rossi E, Bernasconi D, Lim J, Carlson M, Sheffield K, Nekhlyudov L, Grech L, Von Ah D, Mayo S, Ruddy K, Chan A, Alberti P, Lustberg M, Tanay M. Patient perceptions of altering chemotherapy treatment due to peripheral neuropathy. Supportive Care In Cancer 2023, 32: 48. PMID: 38129602, DOI: 10.1007/s00520-023-08209-0.Peer-Reviewed Original ResearchConceptsChemotherapy-induced peripheral neuropathyNeurotoxic chemotherapy treatmentChemotherapy treatmentSymptom resolutionPeripheral neuropathySevere chemotherapy-induced peripheral neuropathyCommon reason participantsMethodsA cross-sectional online surveyBetter patient educationCross-sectional online surveyNeurotoxic chemotherapyCIPN symptomsMedian ageMost patientsTreating clinicianLong-term benefitsPatients' perceptionsPatient educationPractice guidelinesTreatment goalsClinicians' understandingTreatment efficacyConclusionsThis surveyPatientsSymptoms
2020
Racial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer
Paredes AZ, Hyer JM, Palmer E, Lustberg MB, Pawlik TM. Racial/Ethnic Disparities in Hospice Utilization Among Medicare Beneficiaries Dying from Pancreatic Cancer. Journal Of Gastrointestinal Surgery 2020, 25: 155-161. PMID: 32193849, DOI: 10.1007/s11605-020-04568-9.Peer-Reviewed Original ResearchConceptsEthnic minority patientsPancreatic cancerHospice utilizationMinority patientsHospice servicesWhite patientsMedicare Standard Analytic FilesRacial/Ethnic DisparitiesStandard Analytic FilesDeceased individualsTime of deathOverall low useClinical factorsMost patientsMultivariable analysisAnalytic FilesMedicare beneficiariesPancreatectomyPatientsComparable oddsEthnic disparitiesCancerLogistic regressionLow useDeath
2019
Racial/ethnic disparities in hospice utilization among Medicare beneficiaries dying from pancreatic cancer.
Paredes A, Hyer M, Palmer E, Lustberg M, Pawlik T. Racial/ethnic disparities in hospice utilization among Medicare beneficiaries dying from pancreatic cancer. Journal Of Clinical Oncology 2019, 37: 41-41. DOI: 10.1200/jco.2019.37.31_suppl.41.Peer-Reviewed Original ResearchEthnic minority patientsWhite patientsHospice utilizationPancreatic cancerMinority patientsHospice servicesMedicare Standard Analytic FilesStandard Analytic FilesAspects of careTime of deathOverall low useComorbidity burdenMost patientsClinical factorsMultivariable analysisTreatment disparitiesAnalytic FilesMedicare beneficiariesPancreatectomyPatientsComparable oddsEthnic disparitiesCancerEthnic minoritiesLow use